BML Capital Management as of Sept. 30, 2025
Portfolio Holdings for BML Capital Management
BML Capital Management holds 20 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 24.8 | $27M | 14M | 1.90 | |
| Atea Pharmaceuticals (AVIR) | 19.8 | $22M | 7.5M | 2.90 | |
| Adverum Biotechnologies Com New (ADVM) | 12.7 | $14M | 3.1M | 4.53 | |
| Instil Bio Com New (TIL) | 10.6 | $12M | 646k | 17.86 | |
| Oramed Pharmaceuticals Com New (ORMP) | 7.7 | $8.4M | 3.2M | 2.64 | |
| Pmv Pharmaceuticals (PMVP) | 6.8 | $7.4M | 5.3M | 1.40 | |
| Alumis (ALMS) | 4.4 | $4.8M | 1.2M | 3.99 | |
| Lava Therapeutics Nv SHS (LVTX) | 2.8 | $3.1M | 2.0M | 1.56 | |
| Kezar Life Sciences Com New (KZR) | 2.6 | $2.8M | 721k | 3.90 | |
| Connect Biopharma Hldgs SHS | 1.8 | $1.9M | 1.3M | 1.51 | |
| Imagenebio | 1.4 | $1.5M | 183k | 8.15 | |
| Athira Pharma | 1.2 | $1.3M | 323k | 4.14 | |
| Astrotech Corp (ASTC) | 1.0 | $1.1M | 220k | 4.90 | |
| Target Corporation (TGT) | 0.8 | $897k | 10k | 89.70 | |
| Vistagen Therapeutics Ord (VTGN) | 0.5 | $533k | 150k | 3.55 | |
| Wal-Mart Stores Put Option (WMT) | 0.5 | $519k | 265.00 | 1957.50 | |
| Arvinas Ord (ARVN) | 0.4 | $426k | 50k | 8.52 | |
| Lisata Therapeutics (LSTA) | 0.3 | $288k | 110k | 2.62 | |
| Mural Oncology Pub Ord Shs (MURA) | 0.1 | $119k | 58k | 2.07 | |
| Third Harmonic Bio (THRD) | 0.0 | $0 | 3.8M | 0.00 |
